"The new facility is a great addition to our well-established development and scale-up services, says the president of Cambrex's Biopharmaceutical Business Unit, Peter van Hoorn. "With the enhanced capabilities, a dedicated staff of professionals and a well-defined regulatory infrastructure, Cambrex Bio Science is well positioned to be the premier supplier of development and manufacturing services to in the biopharmaceutical industry. The capital investment fits well with our strategy to work with customers on projects early in the development process that feed into clinical and commercial production opportunities."
Continue Reading for Free
Register and gain access to:
- Breaking commercial real estate news and analysis, on-site and via our newsletters and custom alerts
- Educational webcasts, white papers, and ebooks from industry thought leaders
- Critical coverage of the property casualty insurance and financial advisory markets on our other ALM sites, PropertyCasualty360 and ThinkAdvisor
Already have an account? Sign In Now
© 2024 ALM Global, LLC, All Rights Reserved. Request academic re-use from www.copyright.com. All other uses, submit a request to [email protected]. For more information visit Asset & Logo Licensing.
